Immune-mediated rippling muscle disease

Neurology

Volumn 64, Issue 2, 2005, Pages 364-367

  Schulte Mattler, W J ^a   Kley, R A ^b   Rothenfusser Korber E ^a   Bohm S ^c   Bruning T ^c   Hackemann, J ^c   Steinbrecher, A ^a   During M V ^c   Voss, B ^c   Vorgerd, M ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CAVEOLIN 3; CD20 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHLORDANE; CHOLINERGIC RECEPTOR ANTIBODY; CONNECTIN; CREATINE KINASE; DYSFERLIN; DYSTROGLYCAN; DYSTROPHIN; LAMININ ALPHA2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUSCLE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CAVEOLA; ELECTROMYOGRAM; ELECTRON MICROSCOPY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE STIFFNESS; MYALGIA; PRIORITY JOURNAL; RIPPLING MUSCLE DISEASE; SARCOLEMMA; THYMOMA; WESTERN BLOTTING;

EID: 19944433421     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000149532.52938.5B     Document Type: Article

References (10)

1. Vorgerd M, Bolz H, Patzold T, Kubisch C, Malin JP, Mortier W. Phenotypic variability in rippling muscle disease. Neurology 1999;52:453-1459.
2. Betz RC, Schoser BG, Kasper D, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001;28:218-219.
3. Ansevin CF, Agamanolis DP. Rippling muscles and myasthenia gravis with rippling muscles. Arch Neurol 1996;53:197-199.
4. Greenberg SA. Acquired rippling muscle disease with myasthenia gravis. Muscle Nerve 2004;29:143-146.
5. Vernino S, Auger RG, Emslie-Smith AM, Harper CM, Lennon VA. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 1999;53:1233-1239.
6. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002;26:702-707.
7. Ashok MS, Day JW. Autoimmune rippling muscle. Neurology 2003;61:869-870.
8. Takagi A, Kojima S, Watanabe T, Ida M, Kawagoe S. Rippling muscle syndrome preceding malignant lymphoma. Intern Med 2002;41:147-150.
9. Kubisch C, Schoser BG, von During M, et al. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease. Ann Neurol 2003;53:512-520.
10. Minetti C, Bado M, Broda P, et al. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am J Pathol 2002;160:265-270.